Please login to the form below

Not currently logged in
Email:
Password:

Trump

This page shows the latest Trump news and features for those working in and with pharma, biotech and healthcare.

UPDATED: Gilead says remdesivir likely to be effective against new COVID-19 strains

UPDATED: Gilead says remdesivir likely to be effective against new COVID-19 strains

Remdesivir has been touted as a potential treatment for COVID-19 since the early days of the pandemic, with the drug recently being administered to US president Donald Trump after he

Latest news

More from news
Approximately 45 fully matching, plus 101 partially matching documents found.

Latest Intelligence

  • NICE – but not enough NICE – but not enough

    Driving implementation isn’t easy, irrespective of NICE directives; the NHS moves slowly, and local factors will invariably trump national mandates.

  • Eliminating pharmaceutical rebates, is this déjà vu? Eliminating pharmaceutical rebates, is this déjà vu?

    In July 2020, the Trump administration announced its intention, for the second time, to prohibit rebates for Medicare Part D drugs within PBMs as one of several new Executive Orders aimed

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    Other antivirals including hydroxychloroquine – a drug championed by President Donald Trump – and favipiravir are also in clinical development, raising hopes that researchers will find a drug with some level of efficacy

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    A standard malaria treatment: chloroquine and hydroxychloroquine. A decades-old antimalaria drug, chloroquine, entered the global spotlight in March after US President Donald Trump touted it as a potentially effective coronavirus

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    In the early days of the Trump administration, then-FDA commissioner Scott Gottlieb made a point of clearing the way for even faster and more generic approvals, again with some apparent

More from intelligence
Approximately 4 fully matching, plus 22 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...